Published in PLoS Negl Trop Dis on September 06, 2011
Metabolomics: Applications and Promise in Mycobacterial Disease. Ann Am Thorac Soc (2015) 1.96
Serum metabolome and lipidome changes in adult patients with primary dengue infection. PLoS Negl Trop Dis (2013) 0.99
Systems biological approaches to measure and understand vaccine immunity in humans. Semin Immunol (2013) 0.98
The newest "omics"--metagenomics and metabolomics--enter the battle against the neglected tropical diseases. PLoS Negl Trop Dis (2015) 0.90
Statins increase rifampin mycobactericidal effect. Antimicrob Agents Chemother (2014) 0.90
Gene expression profiling specifies chemokine, mitochondrial and lipid metabolism signatures in leprosy. PLoS One (2013) 0.87
Identification of specific metabolites in culture supernatant of Mycobacterium tuberculosis using metabolomics: exploration of potential biomarkers. Emerg Microbes Infect (2015) 0.81
Metabolomics-Based Discovery of Small Molecule Biomarkers in Serum Associated with Dengue Virus Infections and Disease Outcomes. PLoS Negl Trop Dis (2016) 0.81
Metabolomic profiling in cattle experimentally infected with Mycobacterium avium subsp. paratuberculosis. PLoS One (2014) 0.80
Metabonomics reveals drastic changes in anti-inflammatory/pro-resolving polyunsaturated fatty acids-derived lipid mediators in leprosy disease. PLoS Negl Trop Dis (2013) 0.79
Serum proteomic, peptidomic and metabolomic profiles in myasthenia gravis patients during treatment with Qiangji Jianli Fang. Chin Med (2012) 0.78
Metabolite analysis distinguishes between mice with epidermolysis bullosa acquisita and healthy mice. Orphanet J Rare Dis (2013) 0.77
Leprosy Diagnostic Test Development As a Prerequisite Towards Elimination: Requirements from the User's Perspective. PLoS Negl Trop Dis (2016) 0.76
Metabolomic profiling of Burkholderia pseudomallei using UHPLC-ESI-Q-TOF-MS reveals specific biomarkers including 4-methyl-5-thiazoleethanol and unique thiamine degradation pathway. Cell Biosci (2015) 0.76
Profiling of Intracellular Metabolites: An Approach to Understanding the Characteristic Physiology of Mycobacterium leprae. PLoS Negl Trop Dis (2016) 0.75
Global Metabolomic Analysis of a Mammalian Host Infected with Bacillus anthracis. Infect Immun (2015) 0.75
KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res (2009) 28.60
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem (1993) 27.24
Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis (1966) 22.28
pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics (2011) 16.75
Massive gene decay in the leprosy bacillus. Nature (2001) 11.98
Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics (2007) 6.93
Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol (2007) 4.44
The continuing challenges of leprosy. Clin Microbiol Rev (2006) 4.09
LIPID MAPS online tools for lipid research. Nucleic Acids Res (2007) 3.97
Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab (2005) 3.70
The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell (2010) 3.64
Susceptibility to leprosy is associated with PARK2 and PACRG. Nature (2004) 3.07
Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria. Nat Cell Biol (2003) 2.99
Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation (2003) 2.52
Polyunsaturated fatty acids, inflammation, and immunity. Lipids (2001) 2.08
MassTRIX: mass translator into pathways. Nucleic Acids Res (2008) 2.05
Lipid droplet formation in leprosy: Toll-like receptor-regulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis. J Leukoc Biol (2009) 1.89
Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science (2003) 1.73
Global leprosy situation, 2010. Wkly Epidemiol Rec (2010) 1.61
Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest (2008) 1.54
Targeted metabolomics for biomarker discovery. Angew Chem Int Ed Engl (2010) 1.45
The prevalence of previously undiagnosed leprosy in the general population of northwest bangladesh. PLoS Negl Trop Dis (2008) 1.44
Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis. J Biol Chem (2009) 1.36
Polyunsaturated fatty acids block dendritic cell activation and function independently of NF-kappaB activation. J Biol Chem (2005) 1.35
Leprosy and the human genome. Microbiol Mol Biol Rev (2010) 1.27
Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids (2003) 1.24
Population-based molecular epidemiology of leprosy in Cebu, Philippines. J Clin Microbiol (2009) 1.15
Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function. Infect Immun (2002) 1.12
The biology of nerve injury in leprosy. Lepr Rev (2008) 1.08
Identification of fatty acids by electrospray mass spectrometry and tandem mass spectrometry. J Mass Spectrom (1996) 1.07
Leprosy as a genetic disease. Mamm Genome (2010) 1.02
Challenges in the post genomic era for the development of tests for leprosy diagnosis. Rev Soc Bras Med Trop (2008) 0.91
Genetics of host response in leprosy. Lepr Rev (2006) 0.90
Effects of omega-3 and -6 fatty acids on Mycobacterium tuberculosis in macrophages and in mice. Microbes Infect (2008) 0.90
Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease. Neurobiol Aging (2010) 0.90
CE-MS for metabolomics: Developments and applications in the period 2008-2010. Electrophoresis (2010) 0.89
Human leukocyte antigen class I region single-nucleotide polymorphisms are associated with leprosy susceptibility in Vietnam and India. J Infect Dis (2011) 0.88
Evaluation of leprosy patients with 1 to 5 skin lesions with relevance to their grouping into paucibacillary or multibacillary disease. Indian J Dermatol Venereol Leprol (2006) 0.87
Incorporation of a dietary omega 3 fatty acid impairs murine macrophage responses to Mycobacterium tuberculosis. PLoS One (2010) 0.86
Plasma metabolomics reveals biomarkers of the atherosclerosis. J Sep Sci (2010) 0.86
Lysophosphatidylcholine posttranscriptionally inhibits interferon-gamma-induced IP-10, Mig and I-Tac expression in endothelial cells. Cardiovasc Res (2005) 0.81
Tandem mass spectrometry of intact oxidation products of diacylphosphatidylcholines: evidence for the occurrence of the oxidation of the phosphocholine head and differentiation of isomers. J Mass Spectrom (2004) 0.81
Dietary n-3 and n-6 fatty acids: are there 'bad' polyunsaturated fatty acids? Curr Opin Clin Nutr Metab Care (2010) 0.80
Serum lipid profile in leprosy. Indian J Dermatol Venereol Leprol (2010) 0.79
Correlation of serum lipids and lipoproteins in leprosy. Indian J Lepr (1992) 0.78
Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions. Int J Lepr Other Mycobact Dis (1997) 0.77
Essential fatty acids in plasma of patients with leprosy. Int J Lepr Other Mycobact Dis (1991) 0.76
On the origin of leprosy. Science (2005) 4.22
Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol (2011) 3.60
Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat Genet (2009) 2.76
Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med (2003) 2.08
The glycosyltransferases of Mycobacterium tuberculosis - roles in the synthesis of arabinogalactan, lipoarabinomannan, and other glycoconjugates. Glycobiology (2007) 1.89
Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J Clin Invest (2004) 1.89
Chapter 2: Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis. Adv Appl Microbiol (2009) 1.84
Definition of the first mannosylation step in phosphatidylinositol mannoside synthesis. PimA is essential for growth of mycobacteria. J Biol Chem (2002) 1.80
Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-step epimerization of decaprenylphosphoryl ribose. J Bacteriol (2005) 1.71
The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N-terminal recognition region and a C-terminal synthetic region. Mol Microbiol (2003) 1.65
Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis. J Biol Chem (2003) 1.62
Multiple polymorphic loci for molecular typing of strains of Mycobacterium leprae. J Clin Microbiol (2004) 1.60
Ppm1, a novel polyprenol monophosphomannose synthase from Mycobacterium tuberculosis. Biochem J (2002) 1.54
Immunoglobulin G, A, and M responses in serum and circulating immune complexes elicited by the 16-kilodalton antigen of Mycobacterium tuberculosis. Clin Diagn Lab Immunol (2002) 1.46
IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS One (2009) 1.43
Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis. Biochem J (2002) 1.35
Identification, cloning, purification, and enzymatic characterization of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate synthase. Glycobiology (2002) 1.34
Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am J Infect Control (2005) 1.33
Identification of the required acyltransferase step in the biosynthesis of the phosphatidylinositol mannosides of mycobacterium species. J Biol Chem (2003) 1.32
Characterization of a putative alpha-mannosyltransferase involved in phosphatidylinositol trimannoside biosynthesis in Mycobacterium tuberculosis. Biochem J (2002) 1.31
Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection. Infect Immun (2005) 1.29
Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol (2005) 1.27
Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. J Immunol (2005) 1.24
Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells. Nat Immunol (2012) 1.24
Roles of conserved proline and glycosyltransferase motifs of EmbC in biosynthesis of lipoarabinomannan. J Biol Chem (2004) 1.24
Characterization of the Mycobacterium tuberculosis 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase: potential for drug development. J Bacteriol (2007) 1.23
Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans. Microbiology (2002) 1.23
N Glycolylation of the nucleotide precursors of peptidoglycan biosynthesis of Mycobacterium spp. is altered by drug treatment. J Bacteriol (2005) 1.22
Truncated structural variants of lipoarabinomannan in Mycobacterium leprae and an ethambutol-resistant strain of Mycobacterium tuberculosis. J Biol Chem (2004) 1.20
Identification and distribution of Mycobacterium leprae genotypes in a region of high leprosy prevalence in China: a 3-year molecular epidemiological study. J Clin Microbiol (2007) 1.20
Heterologous expression of two Medicago truncatula putative ERF transcription factor genes, WXP1 and WXP2, in Arabidopsis led to increased leaf wax accumulation and improved drought tolerance, but differential response in freezing tolerance. Plant Mol Biol (2007) 1.17
Effect of transporters on the secretion of phytochemicals by the roots of Arabidopsis thaliana. Planta (2006) 1.16
Health system preparedness for bioterrorism: bringing the tabletop to the hospital. Infect Control Hosp Epidemiol (2004) 1.15
Biosynthesis of mycobacterial lipoarabinomannan: role of a branching mannosyltransferase. Proc Natl Acad Sci U S A (2006) 1.15
Population-based molecular epidemiology of leprosy in Cebu, Philippines. J Clin Microbiol (2009) 1.15
Unique structural features of the peptidoglycan of Mycobacterium leprae. J Bacteriol (2007) 1.15
Molecular basis of phosphatidyl-myo-inositol mannoside biosynthesis and regulation in mycobacteria. J Biol Chem (2010) 1.14
Plant neighbor identity influences plant biochemistry and physiology related to defense. BMC Plant Biol (2010) 1.14
Altered profile of secondary metabolites in the root exudates of Arabidopsis ATP-binding cassette transporter mutants. Plant Physiol (2007) 1.13
Mycobacterial lipid II is composed of a complex mixture of modified muramyl and peptide moieties linked to decaprenyl phosphate. J Bacteriol (2005) 1.13
Codominance of TLR2-dependent and TLR2-independent modulation of MHC class II in Mycobacterium tuberculosis infection in vivo. J Immunol (2007) 1.12
Antigen discovery: a postgenomic approach to leprosy diagnosis. Infect Immun (2006) 1.12
New insights into the biosynthesis of mycobacterial lipomannan arising from deletion of a conserved gene. J Biol Chem (2007) 1.11
Towards an immunodiagnostic test for leprosy. Microbes Infect (2006) 1.10
From genome-based in silico predictions to ex vivo verification of leprosy diagnosis. Clin Vaccine Immunol (2009) 1.09
Rapid variable-number tandem-repeat genotyping for Mycobacterium leprae clinical specimens. J Clin Microbiol (2009) 1.09
Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy. Mem Inst Oswaldo Cruz (2012) 1.08
Inactivation of the mycobacterial rhamnosyltransferase, which is needed for the formation of the arabinogalactan-peptidoglycan linker, leads to irreversible loss of viability. J Biol Chem (2004) 1.07
Genetic basis for the synthesis of the immunomodulatory mannose caps of lipoarabinomannan in Mycobacterium tuberculosis. J Biol Chem (2006) 1.07
The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target. Tuberculosis (Edinb) (2008) 1.07
Antigenic specificity of the Mycobacterium leprae homologue of ESAT-6. Infect Immun (2002) 1.06
Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis. Future Microbiol (2013) 1.06
Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan. J Biol Chem (2008) 1.05
Identification of a novel galactosyl transferase involved in biosynthesis of the mycobacterial cell wall. J Bacteriol (2006) 1.05
Are variable-number tandem repeats appropriate for genotyping Mycobacterium leprae? J Clin Microbiol (2008) 1.05
Comparative analysis of B- and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein 10. Infect Immun (2004) 1.04
Transcriptome analysis of Arabidopsis roots treated with signaling compounds: a focus on signal transduction, metabolic regulation and secretion. New Phytol (2008) 1.04
Application of user-guided automated cytometric data analysis to large-scale immunoprofiling of invariant natural killer T cells. Proc Natl Acad Sci U S A (2013) 1.03
Lipoarabinomannan of Mycobacterium: mannose capping by a multifunctional terminal mannosyltransferase. Proc Natl Acad Sci U S A (2008) 1.02
Rice bran fermented with saccharomyces boulardii generates novel metabolite profiles with bioactivity. J Agric Food Chem (2011) 1.02
Genetic diversity of mycobacterium leprae isolates from Brazilian leprosy patients. Lepr Rev (2009) 1.01
Transmission of leprosy in Qiubei County, Yunnan, China: insights from an 8-year molecular epidemiology investigation. Infect Genet Evol (2010) 1.00
Galactosyl transferases in mycobacterial cell wall synthesis. J Bacteriol (2007) 1.00
Expression and characterization of soluble 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase from bacterial pathogens. Chem Biol (2009) 1.00
Polymethylated polysaccharides from Mycobacterium species revisited. J Biol Chem (2008) 1.00
Moving toward elimination of healthcare-associated infections: a call to action. Infect Control Hosp Epidemiol (2010) 0.98
New insights into the early steps of phosphatidylinositol mannoside biosynthesis in mycobacteria: PimB' is an essential enzyme of Mycobacterium smegmatis. J Biol Chem (2009) 0.97
Decaprenyl diphosphate synthesis in Mycobacterium tuberculosis. J Bacteriol (2004) 0.97
Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy. Clin Vaccine Immunol (2010) 0.97
Selection of antigens and development of prototype tests for point-of-care leprosy diagnosis. Clin Vaccine Immunol (2008) 0.96
Rapid and reliable generation of invariant natural killer T-cell lines in vitro. Immunology (2009) 0.96
Isoxyl activation is required for bacteriostatic activity against Mycobacterium tuberculosis. Antimicrob Agents Chemother (2007) 0.96
Hospital-based comparative effectiveness centers: translating research into practice to improve the quality, safety and value of patient care. J Gen Intern Med (2010) 0.96
A continuation: study and characterisation of Mycobacterium leprae short tandem repeat genotypes and transmission of leprosy in Cebu, Philippines. Lepr Rev (2009) 0.94
Phytotoxic catechin leached by seeds of the tropical weed Sesbania virgata. J Chem Ecol (2008) 0.94
Synthesis of 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate and kinetic studies of Mycobacterium tuberculosis IspF. Chem Biol (2010) 0.94
Biosynthetic origin of the galactosamine substituent of Arabinogalactan in Mycobacterium tuberculosis. J Biol Chem (2010) 0.93
Isothermal amplification and molecular typing of the obligate intracellular pathogen Mycobacterium leprae isolated from tissues of unknown origins. J Clin Microbiol (2006) 0.93
Continued proteomic analysis of Mycobacterium leprae subcellular fractions. Proteomics (2004) 0.93
Inhibition of the first step in synthesis of the mycobacterial cell wall core, catalyzed by the GlcNAc-1-phosphate transferase WecA, by the novel caprazamycin derivative CPZEN-45. J Biol Chem (2013) 0.93
"Retention projection" enables reliable use of shared gas chromatographic retention data across laboratories, instruments, and methods. Anal Chem (2013) 0.93
A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone. J Biol Chem (2012) 0.92
A simplified reverse transcriptase PCR for rapid detection of Mycobacterium leprae in skin specimens. FEMS Immunol Med Microbiol (2006) 0.92
Polymerization of mycobacterial arabinogalactan and ligation to peptidoglycan. J Biol Chem (2003) 0.92
Detailed structural and quantitative analysis reveals the spatial organization of the cell walls of in vivo grown Mycobacterium leprae and in vitro grown Mycobacterium tuberculosis. J Biol Chem (2011) 0.92
AftD, a novel essential arabinofuranosyltransferase from mycobacteria. Glycobiology (2009) 0.91
Isolation of a distinct Mycobacterium tuberculosis mannose-capped lipoarabinomannan isoform responsible for recognition by CD1b-restricted T cells. Glycobiology (2012) 0.91
The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy. Lepr Rev (2011) 0.91
A modified synthesis and serological evaluation of neoglycoproteins containing the natural disaccharide of PGL-I from Mycobacterium leprae. Bioorg Med Chem Lett (2010) 0.91